We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

3 hedge funds and large institutions have $2.12M invested in Aethlon Medical in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

22% less capital invested

Capital invested by funds: $2.7M → $2.12M (-$582K)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$111K
2
Northern Trust
Northern Trust
Illinois
-$77K
3
US Bancorp
US Bancorp
Minnesota
-$4K

AEMD Hedge Fund Activity: Q1 2016 in Review

3 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2016, worth a combined $2.12M — down 22% from $2.7M a quarter earlier.

Fund positioning in AEMD was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Bank of New York Mellon, cutting an estimated $111K.

  • 3 institutional investors held Aethlon Medical (AEMD) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $2.12M of Aethlon Medical stock for Q1 2016, down 22% quarter-over-quarter.
  • 0 funds opened new Aethlon Medical positions in Q1 2016 and 0 closed out.
  • The largest Aethlon Medical seller in Q1 2016 was Bank of New York Mellon, an estimated $111K sold.

Based on aggregated 13F filings for Q1 2016.